Просмотр новости
Найдите то, что Вас интересует
Спутники
РН
SpaceX
Роскосмос
NASA
Proposed EU regulation on drug precursors [EU Legislation in Progress]
Дата публикации: 05-06-2026 12:00:00
The EU has put in place a system to address the diversion of drug precursors – substances that have legitimate commercial or industrial applications but are also used to produce illicit drugs. The two regulations in force impose strict conditions on trade in precursors. However, developments in drug markets have created challenges for the existing instruments. To address concerns confronting the EU framework, the Commission has presented a proposal for a regulation that would cover both intra-EU and external trade in these substances. This briefing presents the proposal and keeps track of related legislative developments.
Основное содержимое страницы с новостью.
The EU has put in place a system to address the diversion of drug precursors – substances that have legitimate commercial or industrial applications but are also used to produce illicit drugs. The two regulations in force impose strict conditions on trade in precursors. However, developments in drug markets have created challenges for the existing instruments. To address concerns confronting the EU framework, the Commission has presented a proposal for a regulation that would cover both intra-EU and external trade in these substances. This briefing presents the proposal and keeps track of related legislative developments.
Written by Piotr Bąkowski.
CONTEXTIn the European Union (EU), trade in drug precursors – substances that may have legitimate commercial or industrial applications but are also used to produce illicit drugs – is governed by two regulations, addressing intra-EU and external trade respectively. These laws seek to prevent the diversion of precursors without hindering the commercial interests of lawful operators. However, the mechanism put in place, based on listing individual substances and imposing strict conditions on their trade, has encountered challenges, particularly as a result of developments in drug markets.
To address the concerns confronting the EU framework, several EU policy instruments have announced a revision of the legislation in force. In December 2025, the European Commission presented a proposal that would merge the two regulations. The initiative reflects the European Commission’s intention to reduce the administrative burden for operators and national authorities while setting a regulatory framework more adaptable to drug market developments.
Legislative proposal2025/0384(COD) – Proposal for a regulation of the European Parliament and the Council on monitoring and controlling drug precursors and repealing Regulations (EC) No 273/2004 and (EC) No 111/2005 – (2025) 747 final, 3 December 2025.
NEXT STEPS IN THE EUROPEAN PARLIAMENTFor the latest developments in this legislative procedure, see the Legislative Train Schedule.
Read the complete briefing on ‘Proposed EU regulation on drug precursors‘ in the Think Tank pages of the European Parliament.
Members' Research Service
The central task of the Members Research Service is to ensure that all Members of the European Parliament are provided with analysis of, and research on, policy issues relating to the European Union, in order to assist them in their parliamentary work.
Схожие новости
Классификация: Экономика. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 5.12. Источник: epthinktank.eu.